BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3518041)

  • 1. Bone marrow transplantation in multiple myeloma.
    Tura S; Cavo M; Baccarani M; Ricci P; Gobbi M
    Scand J Haematol; 1986 Feb; 36(2):176-9. PubMed ID: 3518041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation in patients with multiple myeloma: a multicenter comparative analysis of peripheral blood stem cell and allogeneic transplant.
    Varterasian M; Janakiraman N; Karanes C; Abella E; Uberti J; Dragovic J; Raman SB; al-Katib A; Du W; Silver SM; Adams PT; Sensenbrenner L; Ratanatharathorn V
    Am J Clin Oncol; 1997 Oct; 20(5):462-6. PubMed ID: 9345328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.
    Barlogie B; Kyle RA; Anderson KC; Greipp PR; Lazarus HM; Hurd DD; McCoy J; Moore DF; Dakhil SR; Lanier KS; Chapman RA; Cromer JN; Salmon SE; Durie B; Crowley JC
    J Clin Oncol; 2006 Feb; 24(6):929-36. PubMed ID: 16432076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of multiple myeloma by high dose chemotherapy, total body irradiation and autologous blood stem cell autograft.
    Fermand JP; Lévy Y; Gerota J; Benbunan M; Cosset JM; Castaigne S; Seligmann M; Brouet JC
    Nouv Rev Fr Hematol (1978); 1989; 31(2):85-7. PubMed ID: 2570400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma.
    Oken MM; Kyle RA; Greipp PR; Kay NE; Tsiatis A; Gregory SA; Spiegel R J; O'Connell M J
    Leuk Lymphoma; 1996 Feb; 20(5-6):447-52. PubMed ID: 8833401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syngeneic marrow transplantation in multiple myeloma.
    Topolsky D; Crilley P; Leasure N; Bulova S; Brodsky I
    Leuk Res; 1992; 16(4):415-6. PubMed ID: 1564944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
    Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
    Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.
    Attal M; Harousseau JL; Stoppa AM; Sotto JJ; Fuzibet JG; Rossi JF; Casassus P; Maisonneuve H; Facon T; Ifrah N; Payen C; Bataille R
    N Engl J Med; 1996 Jul; 335(2):91-7. PubMed ID: 8649495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
    Blijlevens N; Schwenkglenks M; Bacon P; D'Addio A; Einsele H; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vokurka S; Quinn B; McCann S;
    J Clin Oncol; 2008 Mar; 26(9):1519-25. PubMed ID: 18268357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell depleted bone marrow transplantation for plasma cell myeloma. Report of a case and review of the results of BMT for myeloma.
    Yehuda AB; Or R; Naparstek E; Slavin S; Polliack A
    Blut; 1988 May; 56(5):229-31. PubMed ID: 3285913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
    Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
    Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory and relapsing multiple myeloma treated by blood stem cell transplantation.
    Gertz MA; Pineda AA; Chen MG; Letendre L; Greipp PR; Solberg LA; Witzig TE; Garton JP; Inwards DJ; Litzow MR
    Am J Med Sci; 1995 Mar; 309(3):152-61. PubMed ID: 7879820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of multiple myeloma in stages II and III with melphalan, prednisone, cyclophosphamide, vincristine and BCNU (M-2 protocol)].
    Montalbán C; Sevilla F; Zapatero A; Blanco L; Sabán J; Serrano M; Serrano Ríos M
    Rev Clin Esp; 1985 May; 176(8):392-5. PubMed ID: 3839590
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recent therapy for refractory myeloma].
    Togawa A
    Rinsho Ketsueki; 1993 Apr; 34(4):450-4. PubMed ID: 8510332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chemotherapy on the mobilisation, harvest and economic costs of autologous peripheral stem cell transplantation in patients with multiple myeloma.
    Jerjis S; Croockewit S; Preijers F; Schaap N; De Witte T
    Leuk Lymphoma; 2000 May; 37(5-6):551-60. PubMed ID: 11042515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose chemoradiotherapy and allogenic bone marrow transplantation in multiple myeloma.
    Tura S; Cavo M; Gobbi M; Rosti G; Bandini G; Miggiano C; Albertazzi L; Grimaldi M; Visani G
    Eur J Haematol Suppl; 1989; 51():191-5. PubMed ID: 2697591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation.
    Comenzo RL; Hassoun H; Kewalramani T; Klimek V; Dhodapkar M; Reich L; Teruya-Feldstein J; Fleisher M; Filippa D; Nimer SD
    Leukemia; 2006 Feb; 20(2):345-9. PubMed ID: 16319952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic bone marrow transplantation for plasma cell leukemia following melphalan, cyclophosphamide and total body irradiation.
    De Bock R; Nobels F; Schoemaker I; Van der Planken M; Peetermans M
    Bone Marrow Transplant; 1989 May; 4(3):331. PubMed ID: 2659119
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose etoposide (VP-16)-containing preparatory regimens in allogeneic and autologous bone marrow transplantation for hematologic malignancies.
    Blume KG; Forman SJ
    Semin Oncol; 1992 Dec; 19(6 Suppl 13):63-6. PubMed ID: 1492228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma after autologous bone marrow transplantation for multiple myeloma.
    Vivancos P; Sarrá J; Palou J; Valls A; Garćia J; Grañena A
    Bone Marrow Transplant; 1996 Apr; 17(4):669-71. PubMed ID: 8722373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.